First in Human Study of TORL-2-307-MAB in Participants With Advanced Cancer
Conditions: Advanced Solid Tumor; Gastric Cancer; Pancreas Cancer; Gastroesophageal Junction Adenocarcinoma Intervention: Drug: TORL-2-307-MAB Sponsors: TORL Biotherapeutics, LLC; Translational Research in Oncology Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials